EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

BIST:ECILC.IS

46.1 (TRY) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) TRY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 8,767.3466,479.4961,830.6131,103.515909.132877.076692.094597.9091,412.6451,170.5631,046.7811,126.0091,087.267973.552913.212874.7805.315921.8996.315847.858847.768
Cost of Revenue 5,789.6534,311.2821,166.604762.136608.463561.262447.692363.4761,056.19907.688856.52919.875828.198712.133646.718628.723586.662626.298639.528571.043556.11
Gross Profit 2,977.6932,168.214664.009341.379300.669315.814244.402234.433356.455262.875190.261206.134259.069261.419266.494245.977218.652295.502356.788276.815291.658
Gross Profit Ratio 0.340.3350.3630.3090.3310.360.3530.3920.2520.2250.1820.1830.2380.2690.2920.2810.2720.3210.3580.3260.344
Reseach & Development Expenses 80.282150.9865.9462.0751.7733.3621.1681.3081.851.3611.0981.0530.7040.1390.0160.1910.4594.0657.2617.4085.779
General & Administrative Expenses 454.446477.16774.03233.55528.29720.95616.09418.2828.35526.27325.26723.1650.032101.10191.01686.82383.168109.433100.45189.3230
Selling & Marketing Expenses 677.281,094.854181.84884.84454.11661.45161.55259.245116.42687.49571.82862.09784.221136.493132.56132.021130.96170.473182.39153.660
SG&A 1,131.7261,624.027255.88118.39982.41382.40777.64677.525144.781113.76897.09585.257134.253237.594223.576218.844214.128279.905282.841242.9830
Other Expenses 1,065.354-3,472.37411.4163.2394.62316.668-22.228-6.518-9.681-13.702000.60000471.44825.73817.7310
Operating Expenses 2,277.362-1,697.361476.3254.801185.291190.488192.034178.836310.238258.349205.736196.618263.951250.717215.784230.534222.228283.971290.103250.391142.623
Operating Income 700.3313,865.575687.08691.053297.205224.906208.363129.059154.908123.77918.508134.68322.26610.70250.7115.443-3.57611.53166.68526.42462.987
Operating Income Ratio 0.080.5970.3750.6260.3270.2560.3010.2160.110.1060.0180.120.020.0110.0560.018-0.0040.0130.0670.0310.074
Total Other Income Expenses Net 792.986-763.45-641.7381.39988.761-73.1099.28711.11170.699-25.43-13.272-6.20422.05127.47726.706299.37289.4129.187-6.43717.7584.643
Income Before Tax 1,493.3173,102.1254,578.561939.479385.966193.117295.251170.877197.18873.653-50.85487.0344.639121.20478.19319.02688.751481.76161.96744.1820
Income Before Tax Ratio 0.170.4792.5010.8510.4250.220.4270.2860.140.063-0.0490.0770.0410.1240.0860.3650.110.5230.0620.0520
Income Tax Expense 469.778362.214400.485184.40763.85230.38955.16228.13729.63118.67410.3928.9969.44930.82315.01926.84318.30127.4318.7294.65716.21
Net Income 1,023.6112,739.8384,177.76755.06322.089162.728240.119146.095184.80367.647-43.29361.41432.68988.5160.38290.24972.409454.33143.23839.52446.777
Net Income Ratio 0.1170.4232.2820.6840.3540.1860.3470.2440.1310.058-0.0410.0550.030.0910.0660.3320.090.4930.0430.0470.055
EPS 1.4946.11.10.470.240.350.210.270.11-0.0630.090.0480.130.0880.420.110.660.0630.0580.068
EPS Diluted 1.4946.11.10.470.240.350.210.270.11-0.0630.090.0480.130.0880.420.110.660.0630.0580.068
EBITDA 3,156.5654,409.1164,784.1831,538.318423.687308.422313.514302.994250.092114.1434.66157.21876.12160.33170.05135.72714.809535.452101.5256.931149.035
EBITDA Ratio 0.360.682.6131.3940.4660.3520.4530.5070.1770.0980.0040.140.070.1650.0770.0410.0180.5810.1020.0670.176